{
  "ticker": "GRFS",
  "company_name": "Grifols, S.A.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT02043379",
      "title": "Post-bypass Prophylactic IVIG in Infants and Neonates",
      "status": "COMPLETED",
      "phase": "NA",
      "condition": "Hypogammaglobulinemia, Congenital Heart Disease",
      "start_date": "2014-05",
      "completion_date": "2015-06",
      "enrollment": 0,
      "sponsor": "University of Alabama at Birmingham"
    },
    {
      "nct_id": "NCT03749096",
      "title": "Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome",
      "status": "WITHDRAWN",
      "phase": "PHASE3",
      "condition": "Stiff-Person Syndrome",
      "start_date": "2018-12-07",
      "completion_date": "2019-04-26",
      "enrollment": 0,
      "sponsor": "Mayo Clinic"
    },
    {
      "nct_id": "NCT00486837",
      "title": "Deposition of Inhaled Prolastin in Cystic Fibrosis Patients",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Cystic Fibrosis",
      "start_date": "2003-12",
      "completion_date": "2004-06",
      "enrollment": 0,
      "sponsor": "Grifols Therapeutics LLC"
    },
    {
      "nct_id": "NCT00418483",
      "title": "A Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft Occlusion",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Arterial Occlusive Diseases",
      "start_date": "2007-03",
      "completion_date": "2010-04",
      "enrollment": 0,
      "sponsor": "Grifols Therapeutics LLC"
    },
    {
      "nct_id": "NCT04213950",
      "title": "Improving Adherence to Rabies PEP Guideline Recommendations",
      "status": "COMPLETED",
      "phase": "NA",
      "condition": "Rabies, Rabies Human, Rabies Virus Infection",
      "start_date": "2019-12-29",
      "completion_date": "2020-12-23",
      "enrollment": 0,
      "sponsor": "The Methodist Hospital Research Institute"
    },
    {
      "nct_id": "NCT01222117",
      "title": "A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Acute Peripheral Arterial Occlusion",
      "start_date": "2010-12",
      "completion_date": "2016-01",
      "enrollment": 0,
      "sponsor": "Grifols Therapeutics LLC"
    },
    {
      "nct_id": "NCT02915263",
      "title": "The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies",
      "start_date": "2017-09-11",
      "completion_date": "2022-02-01",
      "enrollment": 0,
      "sponsor": "Beth Israel Deaconess Medical Center"
    },
    {
      "nct_id": "NCT04722887",
      "title": "A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Alpha1-Antitrypsin Deficiency",
      "start_date": "2021-08-13",
      "completion_date": "2025-08-01",
      "enrollment": 0,
      "sponsor": "Grifols Therapeutics LLC"
    },
    {
      "nct_id": "NCT04432324",
      "title": "Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "COVID-19",
      "start_date": "2020-06-02",
      "completion_date": "2021-03-03",
      "enrollment": 0,
      "sponsor": "Instituto Grifols, S.A."
    },
    {
      "nct_id": "NCT04847141",
      "title": "A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection",
      "start_date": "2021-04-28",
      "completion_date": "2021-12-27",
      "enrollment": 0,
      "sponsor": "Grifols Therapeutics LLC"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "NA": 3,
      "PHASE3": 8,
      "PHASE2": 24,
      "PHASE1": 1,
      "PHASE1, PHASE2": 3,
      "PHASE4": 7,
      "": 3,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "COMPLETED": 36,
      "WITHDRAWN": 3,
      "TERMINATED": 5,
      "RECRUITING": 5,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 6,
    "completed_trials": 36,
    "conditions": [
      "ATIII Deficiency",
      "Acquired Antithrombin III Deficiency, Coronary Artery Bypass",
      "Acute Peripheral Arterial Occlusion",
      "Alpha 1-Antitrypsin Deficiency",
      "Alpha1-Antitrypsin Deficiency",
      "Alzheimer's Disease",
      "Amyotrophic Lateral Sclerosis",
      "Arterial Occlusive Diseases",
      "Autoimmune Epilepsy",
      "COVID-19",
      "COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection",
      "Chronic Obstructive Pulmonary Disease",
      "Cirrhosis, Ascites Hepatic",
      "Cirrhosis, Hepatic Encephalopathy",
      "Cirrhosis, Hepatic Encephalopathy, Minimal Hepatic Encephalopathy, Covert Hepatic Encephalopathy",
      "Congenital Afibrinogenemia",
      "Congenital Afibrinogenemia, Hypofibrinogenemia",
      "Cystic Fibrosis",
      "Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies",
      "Dry Eye Disease",
      "Emphysema, Alpha 1-antitrypsin Deficiency (AATD)",
      "Hypogammaglobulinemia, Congenital Heart Disease",
      "Hypogammaglobulinemia, Lung Transplantation",
      "Idiopathic Thrombocytopenic Purpura",
      "Immune Thrombocytopenia",
      "Immune-Mediated Necrotizing Myopathy",
      "Immunologic Deficiency Syndrome",
      "Immunologic Deficiency Syndrome, Agammaglobulinemia, Severe Combined Immunodeficiency, Wiskott-Aldrich Syndrome, Common Variable Immunodeficiency",
      "Myasthenia Gravid",
      "Myasthenia Gravis",
      "Non Cystic Fibrosis Bronchiectasis",
      "Primary Immune Deficiency Disease",
      "Primary Immunodeficiency",
      "Purpura, Thrombocytopenic, Idiopathic",
      "Rabies, Rabies Human, Rabies Virus Infection",
      "Rabies, Rabies Human, Rabies Virus Infection, Pediatrics",
      "Septic Shock, Sepsis",
      "Severe Hemophilia A",
      "Sickle Cell Disease, Pain",
      "Stiff-Person Syndrome",
      "Type 1 Diabetes Mellitus",
      "Von Willebrand Disease"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:18:46.104236",
    "search_query": "Grifols, S.A.",
    "url": "https://clinicaltrials.gov/search?term=Grifols,+S.A."
  }
}